„Checkpoint“
Suchergebnisse
5.704 Treffer
-
Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab
-
Progenitor exhausted PD-1+ T cells are cellular targets of immune checkpoint inhibition in atherosclerosis
-
Human checkpoint proteins hRad9, hHus1, and hRad1 form a DNA damage-responsive complex
-
DNA damage checkpoint pathways and the maintenance of genome stability in C. elegans
-
Crosstalk between tumor-associated macrophages and the B7/CD28 family in immune checkpoint inhibitor-induced immunotherapy
-
Editorial: Molecular architecture and dynamics of meiotic chromosomes
-
Immune Checkpoint Inhibitor plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results
-
Editorial: The roles of checkpoint inhibitors in inflammatory diseases
-
A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)
-
Immune Checkpoint Inhibitors plus Anti-VEGF/Tyrosine Kinase Inhibitors Combined with TACE (Triple Therapy) in Unresectable Hepatocellular Carcinoma
-
Sex differences in the onset and outcomes of immune checkpoint inhibitor-induced overt thyroid dysfunction: a retrospective study
-
Phase 1/2, open-label study of oral bacterial supplementation (EDP1503) plus pembrolizumab in participants with advanced or metastatic microsatellite-stable colorectal cancer, triple-negative breast cancer, and checkpoint inhibitor–relapsed tumors
-
Editorial: Tailoring NK Cell Receptor–Ligand Interactions: An Art in Evolution
-
Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II
-
Editorial: Effector functions of therapeutic antibodies
-
Immune checkpoint inhibitor induces cardiac injury through polarizing macrophages via modulating microRNA-34a/Kruppel-like factor 4 signaling
-
Prognostic risk factors and a survival prediction model for immune checkpoint inhibitor related myocarditis in patients with lung cancer: a multicenter study
-
Immune Checkpoint Inhibitor–Induced Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome: Case Report
-
Immune checkpoint protein inhibitors – Diabetes mellitus: 3 case reports
-
Immune checkpoint protein inhibitors – Polyradiculoneuropathy and Cardiomyopathies: case report